SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending amidst escalating geopolitical tensions, primarily driven by fresh tariff threats from the US administration against European allies, particularly in light of controversial rhetoric regarding Greenland. This has ignited a sharp division among investors, with many anticipating a significant market pullback, while others strongly believe in a swift "buy the dip" recovery, further complicated by discussions around the Japan bond market's stability.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following Saudi Arabia's approval of its Anktiva-based Bioshield protocol for non-small cell lung cancer and broader cancer treatment, alongside ongoing discussions with the FDA for papillary bladder cancer. The community is passionately discussing the potential for a significant short squeeze, viewing the company as a disruptive force in oncology while expressing strong frustration with perceived FDA delays.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as escalating geopolitical tensions, fueled by threats of tariffs and a looming Supreme Court decision on trade policy, generate significant market uncertainty. Community sentiment is sharply divided between those predicting a substantial market downturn due to political instability and those advocating to "buy the dip," expecting resilience from tech and growth stocks.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending amidst intense debate spurred by former President Trump's controversial push for tariffs against European nations, reportedly tied to his interest in Greenland and past grievances. This situation has ignited polarized community discussions concerning potential trade wars and geopolitical repercussions, with many weighing economic stability against his "America First" agenda.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is a prominent trending topic, experiencing pre-market declines amid broader market volatility and geopolitical trade tensions. The community is actively debating a potential "red to green" recovery, with bulls "buying the dip" while bears highlight growing competition from international EV brands and express skepticism about the company's ambitious AI and robotics initiatives. This discussion occurs as the market anticipates upcoming earnings and recent news regarding the company's accelerated AI chip development.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is drawing significant market attention amidst escalating geopolitical discussions surrounding Greenland's vast critical mineral resources and the strategic imperative to secure rare earth supply chains. Community discussion is buzzing around the company's established partnerships for rare earth processing and expectations for updates from a highly anticipated business call, all set against a backdrop of increasing global demand for strategic metals.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors react to confirmed ongoing collaboration with Celestial AI, now acquired by Marvell, validating POET's pivotal role in next-gen AI optical interconnects. The community is buzzing about the company's patented Optical Interposer and its passive alignment technology, which enables highly efficient wafer-scale optical transceiver assembly for AI data centers. Anticipation is high for upcoming customer announcements and the imminent disclosure of fundamental investors, despite ongoing market manipulation concerns.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin (APP) is trending following an investigative report alleging the company's involvement in money laundering for a Southeast Asian gambling group, which has sparked a sharp market sell-off. While some in the community are expressing serious concerns and anticipating further declines, many long-term investors are dismissing the report as a rehashed short attack and are actively buying the dip, expecting a strong rebound following upcoming earnings and management's anticipated defense of the allegations.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The iShares Russell 2000 ETF (IWM) is a central topic amidst escalating trade tensions regarding potential US tariffs on EU goods, stemming from geopolitical demands, and an awaited Supreme Court ruling on existing tariffs. Despite this policy uncertainty, IWM is displaying remarkable relative strength, consistently reaching new highs and outperforming large-cap indices. This robust small-cap performance is prompting community debate, with some viewing it as a healthy market rotation and broadening of growth, while others express caution regarding the profitability of some underlying companies.

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept (VERO) is trending due to Madryn Asset Management acquiring a 91% stake, creating an extremely tight public float that bulls believe is fueling speculation of a massive short squeeze. However, a fierce debate rages with bears warning of a potential pump-and-dump given the company's weak fundamentals and the risk of privatization or delisting at a low payout. The stock experienced significant volatility following its initial surge, leaving investors sharply divided on its near-term trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Michael Thomas Henderson Sells 20,000 Shares of Apogee Therapeutics (NASDAQ:APGE) Stock

Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) CEO Michael Thomas Henderson sold 20,000 shares of the firm's stock in a transaction on Wednesday, January 14th. The shares were sold at an...

Apogee Therapeutics (NASDAQ:APGE) CEO Michael Thomas Henderson Sells 20,000 Shares

Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) CEO Michael Thomas Henderson sold 20,000 shares of the business's stock in a transaction on Wednesday, January 14th. The stock was sold at an...

Apogee Therapeutics (NASDAQ:APGE) Sets New 52-Week High - Here's Why

Apogee Therapeutics (NASDAQ:APGE) Hits New 1-Year High - Here's Why...

Apogee Therapeutics (NASDAQ:APGE) Insider Sells $1,455,608.00 in Stock

Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) insider Carl Dambkowski sold 18,700 shares of the business's stock in a transaction on Wednesday, January 7th. The stock was sold at an...

Apogee Therapeutics (NASDAQ:APGE) Shares Gap Down - What's Next?

Apogee Therapeutics (NASDAQ:APGE) Shares Gap Down - Should You Sell...

Apogee Therapeutics Shares Interim Asthma Data Showing Durable FeNO Drop With APG777 Single Dose

Apogee Therapeutics (NASDAQ:APGE) presented interim Phase 1b data for its IL-13 antibody zumilokibart (APG777) in mild to moderate asthma, highlighting what the company described as a robust and...

Apogee Therapeutics (NASDAQ:APGE) Price Target Raised to $128.00

BTIG Research boosted their target price on Apogee Therapeutics from $115.00 to $128.00 and gave the company a "buy" rating in a report on Monday...

Apogee Therapeutics Inc. (NASDAQ:APGE) Given Average Rating of "Moderate Buy" by Brokerages

Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) has earned an average rating of "Moderate Buy" from the twelve analysts that are covering the firm, Marketbeat reports. One investment analyst...

Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors

Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors There are just nine days left in the year, and this year has flown by. We've delivered readers a steady stream of 2026...

Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month High - What's Next?

Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month High - Here's What Happened...

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.

APGE
Apogee Therapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest APGE News

APGEApogee Therapeutics